Hepatoprotection by L-Ornithine L-Aspartate in Non-Alcoholic Fatty Liver Disease
Background. Non-alcoholic fatty liver disease (NAFLD) is the leading chronic hepatic condition worldwide and new approaches to management and treatment are limited.Summary. L-ornithine L-aspartate (LOLA) has hepatoprotective properties in patients with fatty liver of diverse etiology and results of...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Russo |
| Baskı/Yayın Bilgisi: |
Gastro LLC
2019-03-01
|
| Seri Bilgileri: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
| Konular: | |
| Online Erişim: | https://www.gastro-j.ru/jour/article/view/322 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|